18 Sep Amplify MedTech – De-risking MedTech Product Development – From Idea to FDA
Amplify MedTech Recap – De-risking MedTech Product Development – From Idea to FDA
On September 18, 2025, Amplify MedTech’s Dr. Fehmida Kapadia hosted an hour-long online panel on de-risking medtech product development, featuring insights from Lauren Eskew (Key Tech) and serial entrepreneur Steve Schaefer (CoolTech/MiHelper). The discussion explored early-stage challenges like product-market fit, regulatory strategy, and subsystem risk reduction, as well as best practices for usability, manufacturability, and scaling. The speakers emphasized designing with the end in mind, setting clear pass/fail criteria, and strategically sequencing features to balance innovation, regulatory approval, and commercial success.
Watch the full episode here:
Latest posts by Alexis McKenzie (see all)
- Ep 45 How We Ran a Clinical Study Without Millions - June 9, 2026
- Ep 44 The Real Cost of Adding Cybersecurity Late in Medical Device Development - February 4, 2026
- Ep 43 MedTech’s 11 Year Exit Problem— and What It Means for Raising Capital - December 12, 2025